# Ne oldu?

The U.S. Food and Drug Administration (FDA) has issued an early alert concerning Boston Scientific's Imager II Angiographic Catheters. The alert stems from a potentially high-risk device issue identified by the manufacturer. Boston Scientific sent a letter to affected customers on August 24 recommending that all Imager II Angiographic Catheters be immediately removed from use or sale and segregated. The FDA is issuing this alert to notify the public and healthcare providers of the issue, noting that the agency will continue to update the public as significant new information becomes available.

# Ayrıntılar

According to the FDA's early alert, the core concern relates to the integrity of the Imager II Angiographic Catheters during angiographic procedures. These devices are used to create images of specific areas of interest in the peripheral vasculature. Boston Scientific's notification to customers emphasized the need to immediately stop further use or distribution of the affected product. The company instructed users to verify whether their inventory is affected by checking the Unit Package Number (UPN), considering both inner and outer packaging codes. Affected users are directed to complete a Reply Verification Tracking Form (RVTF) to quantify the units being returned and return the product to Boston Scientific.

# Neden önemli?

This alert is significant because it involves a class of devices used in interventional cardiology and radiology to visualize the peripheral vasculature. A device integrity issue during such procedures could potentially impact patient safety and procedural outcomes. The FDA's issuance of an early alert—rather than a full recall notice at this stage—indicates an active effort to inform the market quickly while information is still being assessed. Healthcare providers and facilities using these catheters need to be aware of the recommendation to segregate and potentially return the devices to mitigate risk.

# Sırada ne var?

The FDA has stated it will keep the public informed and update the relevant web page as significant new information becomes available. Boston Scientific is reportedly working with affected customers to process returns. Healthcare facilities are urged to check their inventory of Imager II Angiographic Catheters immediately using the UPN verification process outlined in the manufacturer's letter to determine if they possess affected units.